AI/ML Innovations Inc. Announces Closing of Financing

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has completed a non-brokered private placement, raising $392,250 through the issuance of 7,845,000 units at $0.05 per unit. Each unit comprises one common share and one warrant, exercisable at $0.10 for two years. The company paid $18,200 in finder's fees and issued 364,000 broker warrants. An insider subscribed for 23.96% of the units. The net proceeds will be used for working capital. Securities are subject to a hold period until December 20, 2024. AI/ML focuses on AI and machine learning investments in digital health and wellbeing companies.

Positive

• Raised $392,250 in new capital through private placement
• Insider participation in the financing, showing management confidence
• Warrants provide potential for additional future funding at $0.10 per share

Negative

• Dilution of existing shareholders due to issuance of new shares
• Low price of $0.05 per unit suggests weak market valuation
• Additional dilution possible if warrants are exercised

VICTORIA, BC / ACCESSWIRE / August 19, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it has completed its previously announced non-brokered private placement (the "Financing") on August 19, 2024. The Company accepted subscriptions of 7,845,000 units at a price of $0.05 per unit, for gross proceeds of $392,250. The Company paid finders fees to qualified finders of $18,200 and issued 364,000 broker warrants, which are on the same terms as the warrants forming part of the Units.

Each Unit is comprised of one Common Share and one Warrant which will be exercisable into one (1) Common Share of the Company (each a "Warrant Share"). Each Warrant will have a term of two (2) years and will entitle the holder to purchase one (1) Warrant Share at a price of $0.10 per share following the closing date, subject to the Company's right to accelerate expiry upon 30 days' notice if the shares trade at $0.25 for a for a period of at least 20 consecutive trading days.

One insider subscribed for 2,000,000 Units of the Company, representing 23.96 % of the Units issued. As such participation was less than 25% of the market capitalization of the Company at the time, the Company has relied on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(a) of MI 61-101 in respect of such insider participation.

Securities issued on this closing are subject to a statutory hold period until December 20, 2024.

The Company intends to use net proceeds of the Private Placement for working capital requirements.

For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.

About AI/ML Innovations Inc. https://aiml-innovations.com/
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (22% ownership commitment by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.

Forward-Looking Statement Disclaimer

Certain statements contained in this release may constitute "forward-looking statements" or "forward-looking information" (collectively "forward-looking information") as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated", "anticipates" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Certain statements contained in this release may constitute "forward-looking statements" or "forward-looking information" (collectively "forward-looking information") as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated", "anticipates" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the RN Property, the Acquirors and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: AI/ML Innovations, Inc.

View the original press release on accesswire.com

FAQ

How much did AI/ML Innovations Inc. (AIMLF) raise in its recent financing?

AI/ML Innovations Inc. (AIMLF) raised $392,250 in gross proceeds through its non-brokered private placement completed on August 19, 2024.

What is the exercise price and term of the warrants issued by AI/ML Innovations (AIMLF) in the August 2024 financing?

The warrants issued by AI/ML Innovations (AIMLF) have an exercise price of $0.10 per share and a term of two years from the closing date of the financing on August 19, 2024.

When does the statutory hold period end for securities issued in AI/ML Innovations' (AIMLF) August 2024 financing?

The statutory hold period for securities issued in AI/ML Innovations' (AIMLF) August 2024 financing ends on December 20, 2024.

What is AI/ML Innovations Inc.'s (AIMLF) primary business focus?

AI/ML Innovations Inc. (AIMLF) focuses on investments in artificial intelligence (AI) and machine learning (ML) companies, particularly in the digital health and wellbeing sectors.